Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Inventory (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Change in Inventory data on record, last reported at -$3.2 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 3.95% year-over-year to -$3.2 million; the TTM value through Dec 2025 reached $3.0 million, up 9.58%, while the annual FY2025 figure was $9.3 million, 138.11% up from the prior year.
  • Change in Inventory reached -$3.2 million in Q4 2025 per PBH's latest filing, down from $5.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $16.8 million in Q4 2022 and bottomed at -$13.6 million in Q4 2023.
  • Average Change in Inventory over 5 years is $1.6 million, with a median of $875500.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: tumbled 18300.0% in 2021, then soared 1103.41% in 2022.
  • A 5-year view of Change in Inventory shows it stood at -$1.7 million in 2021, then skyrocketed by 1103.41% to $16.8 million in 2022, then plummeted by 180.87% to -$13.6 million in 2023, then soared by 77.25% to -$3.1 million in 2024, then decreased by 3.95% to -$3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$3.2 million in Q4 2025, $5.8 million in Q3 2025, and $4.4 million in Q2 2025.